Patrick Morand

Patrick Morand

President atOpen PrairieIllinois

Patrick Morand is President of Open Prairie with over 35 years in investment and management, focusing on regulated industries and turnarounds. He previously led life science funds and companies.

What Patrick can write

Writes checks of$1M to $10M
Comes in atSeries A, Series BCan lead the round
Ownership target7-10%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Open Prairie writes $1M to $10M checks, larger than 83% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Open Prairie.

Career

  1. Southwest Michigan First Life Science Fund · Managing Director
  2. Genesis Therapeutics · Vice President of Commercial Operations
  3. Sequitor Medical Technologies · Executive Vice President
  4. Pittsburgh Life Sciences Greenhouse · Executive in Residence
  5. Open Prairie · President
    Now

Focus

life sciencesagricultureturnaround managementinvestor relationsregulated industriesinvestment

Education

Athenaeum of Ohio

Also at Open Prairie

Partners like Patrick

At firms with a similar stage, sector and check size.

Alert me when Open Prairie is active

One email when Patrick's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Patrick Morand?

Patrick Morand is President of Open Prairie with over 35 years in investment and management, focusing on regulated industries and turnarounds. He previously led life science funds and companies.

How much does Patrick Morand invest?

Patrick Morand invests through Open Prairie, which writes checks of $1M to $10M at series a, series b.

How do I pitch Patrick Morand?

A warm intro from a founder Open Prairie backed works best.

What did Patrick Morand do before Open Prairie?

Managing Director at Southwest Michigan First Life Science Fund; Vice President of Commercial Operations at Genesis Therapeutics; Executive Vice President at Sequitor Medical Technologies; Executive in Residence at Pittsburgh Life Sciences Greenhouse.

Last updated 2026-10-15. Is this you? Ask for a correction.